Applied Therapeutics IncNASDAQ:APLT
- LAST PRICE4.2300
- TODAY'S CHANGE (%)-0.0800 (-1.8561%)
- Bid / Lots4.1500/ 2
- Ask / Lots5.2000/ 1
- Open / Previous Close4.2000 / 4.3100
- Day Range
- 52 Week Range
- Volume568,591
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APLT |
|---|---|---|
| 09:32 ET | 9263 | 4.21 |
| 09:34 ET | 6218 | 4.21 |
| 09:36 ET | 1579 | 4.22 |
| 09:38 ET | 220 | 4.22 |
| 09:39 ET | 2855 | 4.21 |
| 09:41 ET | 7464 | 4.24 |
| 09:43 ET | 603 | 4.26 |
| 09:45 ET | 3033 | 4.29 |
| 09:48 ET | 2081 | 4.33 |
| 09:50 ET | 1658 | 4.35 |
| 09:52 ET | 3873 | 4.31 |
| 09:54 ET | 1784 | 4.27 |
| 09:56 ET | 1486 | 4.21 |
| 09:57 ET | 225 | 4.21 |
| 09:59 ET | 363 | 4.215 |
| 10:01 ET | 618 | 4.17 |
| 10:03 ET | 3252 | 4.18 |
| 10:06 ET | 2500 | 4.2 |
| 10:08 ET | 1610 | 4.25 |
| 10:10 ET | 900 | 4.24 |
| 10:12 ET | 250 | 4.25 |
| 10:14 ET | 900 | 4.27 |
| 10:15 ET | 1193 | 4.29 |
| 10:17 ET | 100 | 4.31 |
| 10:19 ET | 2342 | 4.305 |
| 10:24 ET | 200 | 4.26 |
| 10:26 ET | 600 | 4.245 |
| 10:28 ET | 1250 | 4.235 |
| 10:30 ET | 1050 | 4.2412 |
| 10:32 ET | 689 | 4.24 |
| 10:33 ET | 745 | 4.19 |
| 10:35 ET | 396 | 4.19 |
| 10:39 ET | 700 | 4.18 |
| 10:42 ET | 100 | 4.18 |
| 10:44 ET | 400 | 4.195 |
| 10:46 ET | 7195 | 4.21 |
| 10:48 ET | 590 | 4.21 |
| 10:50 ET | 500 | 4.2 |
| 10:51 ET | 200 | 4.2 |
| 10:53 ET | 400 | 4.2 |
| 10:55 ET | 230 | 4.19 |
| 10:57 ET | 600 | 4.19 |
| 11:00 ET | 348 | 4.2 |
| 11:02 ET | 850 | 4.2 |
| 11:04 ET | 2350 | 4.2037 |
| 11:06 ET | 200 | 4.215 |
| 11:08 ET | 600 | 4.21 |
| 11:09 ET | 1374 | 4.2 |
| 11:11 ET | 700 | 4.21 |
| 11:13 ET | 621 | 4.22 |
| 11:15 ET | 100 | 4.22 |
| 11:18 ET | 4558 | 4.24 |
| 11:20 ET | 4070 | 4.22 |
| 11:22 ET | 1071 | 4.22 |
| 11:24 ET | 4091 | 4.23 |
| 11:26 ET | 200 | 4.23 |
| 11:27 ET | 1000 | 4.24 |
| 11:29 ET | 200 | 4.23 |
| 11:31 ET | 1155 | 4.23 |
| 11:33 ET | 7301 | 4.185 |
| 11:36 ET | 2072 | 4.1977 |
| 11:38 ET | 300 | 4.19 |
| 11:40 ET | 700 | 4.19 |
| 11:42 ET | 1071 | 4.195 |
| 11:44 ET | 400 | 4.195 |
| 11:45 ET | 4485 | 4.2 |
| 11:47 ET | 1407 | 4.22 |
| 11:49 ET | 4337 | 4.23 |
| 11:51 ET | 978 | 4.24 |
| 11:54 ET | 1021 | 4.23 |
| 11:56 ET | 5670 | 4.28 |
| 11:58 ET | 1017 | 4.25 |
| 12:02 ET | 2197 | 4.28 |
| 12:03 ET | 200 | 4.28 |
| 12:05 ET | 100 | 4.27 |
| 12:07 ET | 200 | 4.26 |
| 12:09 ET | 100 | 4.27 |
| 12:12 ET | 1492 | 4.245 |
| 12:14 ET | 5630 | 4.29 |
| 12:16 ET | 500 | 4.25 |
| 12:18 ET | 4686 | 4.25 |
| 12:20 ET | 492 | 4.26 |
| 12:21 ET | 300 | 4.27 |
| 12:23 ET | 100 | 4.26 |
| 12:25 ET | 200 | 4.25 |
| 12:27 ET | 300 | 4.25 |
| 12:30 ET | 300 | 4.26 |
| 12:32 ET | 564 | 4.26 |
| 12:34 ET | 300 | 4.25 |
| 12:36 ET | 100 | 4.25 |
| 12:38 ET | 372 | 4.26 |
| 12:39 ET | 100 | 4.26 |
| 12:41 ET | 100 | 4.25 |
| 12:43 ET | 1918 | 4.26 |
| 12:45 ET | 600 | 4.2601 |
| 12:48 ET | 700 | 4.25 |
| 12:52 ET | 1994 | 4.265 |
| 12:54 ET | 400 | 4.27 |
| 12:56 ET | 1200 | 4.27 |
| 12:57 ET | 1839 | 4.26 |
| 12:59 ET | 2325 | 4.265 |
| 01:01 ET | 1333 | 4.27 |
| 01:03 ET | 1522 | 4.26 |
| 01:08 ET | 4900 | 4.26 |
| 01:10 ET | 1949 | 4.26 |
| 01:14 ET | 400 | 4.27 |
| 01:15 ET | 8297 | 4.27 |
| 01:17 ET | 100 | 4.265 |
| 01:19 ET | 200 | 4.265 |
| 01:21 ET | 1533 | 4.26 |
| 01:24 ET | 620 | 4.245 |
| 01:26 ET | 500 | 4.245 |
| 01:28 ET | 2053 | 4.25 |
| 01:30 ET | 1525 | 4.26 |
| 01:32 ET | 100 | 4.27 |
| 01:33 ET | 100 | 4.27 |
| 01:35 ET | 600 | 4.29 |
| 01:37 ET | 300 | 4.29 |
| 01:39 ET | 700 | 4.31 |
| 01:42 ET | 100 | 4.31 |
| 01:44 ET | 382 | 4.31 |
| 01:46 ET | 100 | 4.32 |
| 01:48 ET | 1873 | 4.33 |
| 01:50 ET | 400 | 4.33 |
| 01:51 ET | 100 | 4.33 |
| 01:55 ET | 425 | 4.31 |
| 01:57 ET | 300 | 4.32 |
| 02:00 ET | 800 | 4.315 |
| 02:02 ET | 3831 | 4.29 |
| 02:04 ET | 100 | 4.28 |
| 02:08 ET | 300 | 4.27 |
| 02:09 ET | 200 | 4.28 |
| 02:11 ET | 1075 | 4.27 |
| 02:13 ET | 400 | 4.27 |
| 02:15 ET | 200 | 4.28 |
| 02:18 ET | 603 | 4.27 |
| 02:20 ET | 500 | 4.28 |
| 02:22 ET | 4146 | 4.305 |
| 02:24 ET | 550 | 4.295 |
| 02:26 ET | 339 | 4.3 |
| 02:27 ET | 274 | 4.3 |
| 02:29 ET | 400 | 4.2999 |
| 02:31 ET | 685 | 4.3 |
| 02:33 ET | 1468 | 4.26 |
| 02:38 ET | 205 | 4.25 |
| 02:40 ET | 400 | 4.25 |
| 02:42 ET | 100 | 4.265 |
| 02:44 ET | 1086 | 4.25 |
| 02:45 ET | 2828 | 4.27 |
| 02:47 ET | 400 | 4.275 |
| 02:49 ET | 1095 | 4.27 |
| 02:51 ET | 547 | 4.27 |
| 02:54 ET | 588 | 4.28 |
| 02:56 ET | 1191 | 4.28 |
| 02:58 ET | 200 | 4.275 |
| 03:00 ET | 300 | 4.27 |
| 03:02 ET | 2900 | 4.3 |
| 03:03 ET | 292 | 4.295 |
| 03:05 ET | 3421 | 4.295 |
| 03:07 ET | 180 | 4.3 |
| 03:09 ET | 300 | 4.295 |
| 03:12 ET | 1530 | 4.28 |
| 03:14 ET | 2116 | 4.275 |
| 03:16 ET | 100 | 4.27 |
| 03:18 ET | 100 | 4.275 |
| 03:20 ET | 3410 | 4.3 |
| 03:21 ET | 200 | 4.31 |
| 03:23 ET | 200 | 4.3 |
| 03:25 ET | 500 | 4.3 |
| 03:27 ET | 200 | 4.3 |
| 03:30 ET | 200 | 4.295 |
| 03:32 ET | 7173 | 4.32 |
| 03:34 ET | 393 | 4.32 |
| 03:36 ET | 200 | 4.315 |
| 03:38 ET | 3700 | 4.32 |
| 03:39 ET | 4788 | 4.31 |
| 03:41 ET | 3144 | 4.28 |
| 03:43 ET | 1197 | 4.28 |
| 03:45 ET | 1664 | 4.28 |
| 03:48 ET | 11907 | 4.28 |
| 03:50 ET | 5737 | 4.275 |
| 03:52 ET | 6129 | 4.26 |
| 03:54 ET | 16449 | 4.255 |
| 03:56 ET | 16467 | 4.24 |
| 03:57 ET | 40712 | 4.27 |
| 03:59 ET | 24905 | 4.23 |
Apr 15, 2024
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer, from 7:00AM ET on Monday Apr 15, 2024 by Dow Jones
7:00AM ET on Monday Apr 15, 2024 by Dow JonesPress Release: Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer, from 7:00AM ET on Monday Apr 15, 2024 by Dow Jones
7:00AM ET on Monday Apr 15, 2024 by Dow Jones
Apr 11, 2024
DJ Applied Therapeutics Price Target Maintained With a $12.00/Share by RBC Capital, from 10:42AM ET on Thursday Apr 11, 2024 by Dow Jones
10:42AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 4, 2024
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024, from 7:00AM ET on Thursday Apr 04, 2024 by Dow Jones
7:00AM ET on Thursday Apr 04, 2024 by Dow Jones
Mar 28, 2024
DJ Stocks to Watch: Torrid, Applied Therapeutics, Doma, from 7:58PM ET on Thursday Mar 28, 2024 by Dow Jones
7:58PM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Applied Therapeutics Inc | 492.4M | -3.0x | --- |
Absci Corp | 510.9M | -3.7x | --- |
Arbutus Biopharma Corp | 495.5M | -6.2x | --- |
Astria Therapeutics Inc | 494.1M | -3.9x | --- |
AnaptysBio Inc | 515.7M | -3.1x | --- |
Altimmune Inc | 501.9M | -4.4x | --- |
Company Information
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Contact Information
- Headquarters
- 545 FIFTH AVENUE, SUITE 1400NEW YORK, NY, United States 10017
- Phone
- 212-220-9226
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer, Founder
- Shoshana Shendelman
- Chief Financial Officer and Principal Financial Officer, Director
- Leslie Funtleyder
- Chief Operating Officer and Chief Business Officer
- Constantine Chinoporos
- Interim Principal Financial Officer, Chief Accounting Officer
- Catherine Thorpe
- Chief Commercial Officer
- Dale Hooks
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $492.4M |
|---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 114.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.91 |
EPS | $-1.42 |
Book Value | $-0.20 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | 49.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -645.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
